Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
PLoS One. 2020 Apr 17;15(4):e0231447. doi: 10.1371/journal.pone.0231447. eCollection 2020.
The enhanced recovery after surgery (ERAS) protocol for colorectal cancer resection recommends balanced perioperative fluid therapy. According to recent guidelines, zero-balance fluid therapy is recommended in low-risk patients, and immediate correction of low urine output during surgery is discouraged. However, several reports have indicated an association of intraoperative oliguria with postoperative acute kidney injury (AKI). We investigated the impact of intraoperative oliguria in the colorectal ERAS setting on the incidence of postoperative AKI.
From January 2017 to August 2019, a total of 453 patients underwent laparoscopic colorectal cancer resection with the ERAS protocol. Among them, 125 patients met the criteria for oliguria and were propensity score (PS) matched to 328 patients without intraoperative oliguria. After PS matching had been performed, 125 patients from each group were selected and the incidences of AKI were compared between the two groups. Postoperative kidney function and surgical outcomes were also evaluated.
The incidence of AKI was significantly higher in the intraoperative oliguria group than in the non-intraoperative oliguria group (26.4% vs. 11.2%, respectively, P = 0.002). Also, the eGFR reduction on postoperative day 0 was significantly greater in the intraoperative oliguria than non-intraoperative oliguria group (-9.02 vs. -1.24 mL/min/1.73 m2 respectively, P < 0.001). In addition, the surgical complication rate was higher in the intraoperative oliguria group than in the non-intraoperative oliguria group (18.4% vs. 9.6%, respectively, P = 0.045).
Despite the proven benefits of perioperative care with the ERAS protocol, caution is required in patients with intraoperative oliguria to prevent postoperative AKI. Further studies regarding appropriate management of intraoperative oliguria in association with long-term prognosis are needed in the colorectal ERAS setting.
结直肠肿瘤切除术的加速康复外科(ERAS)方案建议行围术期平衡输液治疗。根据最近的指南,低危患者推荐行零平衡输液治疗,且不鼓励术中即刻纠正少尿。然而,有几项报告表明术中少尿与术后急性肾损伤(AKI)有关。我们调查了结直肠 ERAS 背景下,术中少尿对术后 AKI 发生率的影响。
2017 年 1 月至 2019 年 8 月,共有 453 例患者接受腹腔镜结直肠肿瘤切除术和 ERAS 方案。其中 125 例患者符合少尿标准,并与 328 例无术中少尿的患者进行倾向评分(PS)匹配。进行 PS 匹配后,每组各选择 125 例患者,比较两组的 AKI 发生率。还评估了术后肾功能和手术结果。
术中少尿组 AKI 发生率明显高于非术中少尿组(分别为 26.4%和 11.2%,P=0.002)。此外,术中少尿组术后第 0 天的 eGFR 下降明显大于非术中少尿组(分别为-9.02 和-1.24 mL/min/1.73 m2,P<0.001)。此外,术中少尿组的手术并发症发生率高于非术中少尿组(分别为 18.4%和 9.6%,P=0.045)。
尽管围手术期 ERAS 方案的护理有明确的益处,但对于术中少尿的患者仍需谨慎,以预防术后 AKI。在结直肠 ERAS 背景下,需要进一步研究术中少尿与长期预后相关的适当管理。